Table 1.
Hyperglycemia-ischemia (HGI) specific change in phosphorylation of signaling proteins involved in the NF-κB pathway.
| Phospho-protein site | Change in phosphorylation | Reference to NF-κB involvement |
|---|---|---|
| P38 MAPK (Phospho-Thr180) | Up | (21–23) |
| AKT1 (Phospho-Tyr474) | Up | (24) |
| Ras-GRF1 (Phospho-Ser916) | Up | (25, 26) |
| HDAC1 (Phospho-Ser421) | Up | (27) |
| NF-κB-p100 (Phopho-Ser872) | Up | (28) |
| BLNK (Phopho-Tyr96) | Up | (29) |
| BLNK (Phopho-Tyr84) | Up | |
| IKK gamma (Phopho-Ser85) | UP | (30) |
| PKC theta (Phopho-Ser676) | Down | (31, 32) |
| PKR (Phospho-Thr446) | Down | (33) |
| PKR (Phopho-Thr451) | Down | |
| PKC beta (Phospho-Ser661) | Down | |
| PKC zeta (Phospho-Thr410) | Down | (31, 32, 34) |
| HDAC5 (Phopho-Ser259) | Down | |
| SAPK/JNK (Phospho-Thr183) | Down | |
| IκB-alpha (Phopho-Ser32/36) | Down | (35) |
| NF-κB-p65 (Phopho-Thr435) | Down | (36) |
| LCK (Phopho-Tyr505) | Down |